Correlation Between Visa and Curative Biotechnology

Can any of the company-specific risk be diversified away by investing in both Visa and Curative Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Curative Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Curative Biotechnology, you can compare the effects of market volatilities on Visa and Curative Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Curative Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Curative Biotechnology.

Diversification Opportunities for Visa and Curative Biotechnology

-0.04

Correlation Coefficient

Visa  Curative Biotechnology

Good diversification

The 3 months correlation between Visa and Curative is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Curative Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biotechnology and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Curative Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biotechnology has no effect on the direction of Visa i.e., Visa and Curative Biotechnology go up and down completely randomly.

Pair Corralation between Visa and Curative Biotechnology

Taking into account the 90-day investment horizon Visa is expected to generate 82.16 times less return on investment than Curative Biotechnology. But when comparing it to its historical volatility, Visa Class A is 79.61 times less risky than Curative Biotechnology. It trades about 0.08 of its potential returns per unit of risk. Curative Biotechnology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  2.75  in Curative Biotechnology on October 24, 2024 and sell it today you would lose (1.45) from holding Curative Biotechnology or give up 52.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.18%
Values	Daily Returns

Visa Class A  vs.  Curative Biotechnology

Visa Class A

Risk-Adjusted Performance

16 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.

Curative Biotechnology

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Curative Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental drivers, Curative Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and Curative Biotechnology

The main advantage of trading using opposite Visa and Curative Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Curative Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biotechnology will offset losses from the drop in Curative Biotechnology's long position.

The idea behind Visa Class A and Curative Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.